Navigation

Epidermal growth factor receptor tyrosine kinase (EGFR-TK) mutation testing in adults with locally advanced or metastatic non-small-cell lung cancer

Epidermal growth factor receptor tyrosine kinase (EGFR-TK) mutation testing in adults with locally advanced or metastatic non-small-cell lung cancer

Status: History
Publication Date: August 2013
Topic area:
 

NICE project team

Patient involvement Lead: Laura Norburn
Lead analyst: Farouk Saeed
Communications manager: Phil Ranson
Project manager: Robert Fernley
Implementation Lead: Katie Perryman-Ford
Top


 

Provisional schedule

Scoping workshop: 6 July 2012
1st committee meeting: 06 March 2013
2nd committee meeting 08 May 2013
Consultation on guidance: 08 April 2013
Top


 

Stakeholders

Manufacturer(s)

  • Qiagen
  • Roche Molecular Systems

Professional groups

  • British Thoracic Oncology Group (BTOG)
  • Royal College of Pathologists
  • Royal College of Physicians

Patient/carer groups

  • Cancer Research UK

External Assessment Group

  • Kleijnen Systematic Reviews Ltd

Others

  • All Wales Molecular Genetics Lab
  • AstraZeneca
  • Boehringer Ingelheim Limited
  • Bristol Genetics Laboratory  
  • Coventry and Warwickshire Pathology Services
  • Department of Health
  • European Molecular Genetics Quality Network
  • Guy's and St.Thomas' NHS Foundation Trust
  • Health Improvement Scotland
  • Leeds Teaching Hospital
  • New Gene Ltd
  • NHS Grampian
  • NHS Greater Glasgow and Clyde
  • Oxford University Hospitals Trust
  • Royal Devon and Exter NHS Trust
  • Royal Liverpool University Hospital 
  • Sheffield Diagnostics Genetics Service
  • St Mary's Hospital
  • The Lothian University Hospitals
  • UCL Advanced Diagnostics
  • UK NEQAS (Edinburgh)
  • University Hospitals Birmingham NHS
  • ViennaLab Diagnostics GmbH

Definition:

Registered stakeholders

Individuals or organisations interested in a topic being evaluated by the Diagnostics Assessment Programme, and who register to become a stakeholder. For example, manufacturers of the technology, national organisations that represent healthcare professions who operate or use the results of the technology, national patient or carer organisations, NHS service providers and commissioners, statutory organisations and research organisations.

Top


 

Key documents

This page was last updated: 08 August 2013

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.